Total: 11 |
|
PMID (PMCID) | ||
---|---|---|
30762251 |
MIXED_SAMPLE | Child |
Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature. | ||
Muguet Guenot L, Aubert H, Isidor B, Toutain A, Mazereeuw-Hautier J, Collet C, Bourrat E, Denis Musquer M, Barbarot S. Pediatr Dermatol. 2019;36(2):242-246. |
||
Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature. | ||
30168875 |
MIXED_SAMPLE | Child |
Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients. | ||
Yasuda M, Morimoto N, Shimizu A, Toyoshima T, Yokoyama Y, Ishikawa O. J Dermatol. 2018;45(11):1357-1361. |
||
Familial acanthosis nigricans caused by the mutation of the fibroblast growth factor receptor 3 (FGFR3) gene is characterized by short stature, hypochondroplasia and acanthosis nigricans. | ||
28181399 |
MALE | Child |
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. | ||
Couser NL, Pande CK, Turcott CM, Spector EB, Aylsworth AS, Powell CM. Am J Med Genet A. 2017;173(4):1097-1101. |
||
Pathogenic allelic variants in the fibroblast growth factor receptor 3 (FGFR3) gene have been associated with a number of phenotypes including achondroplasia, hypochondroplasia, thanatophoric dysplasia, Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome), and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans). | ||
28181399 |
MALE | Child |
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. | ||
Couser NL, Pande CK, Turcott CM, Spector EB, Aylsworth AS, Powell CM. Am J Med Genet A. 2017;173(4):1097-1101. |
||
Pathogenic allelic variants in the fibroblast growth factor receptor 3 (FGFR3) gene have been associated with a number of phenotypes including achondroplasia, hypochondroplasia, thanatophoric dysplasia, Crouzon syndrome with acanthosis nigricans (Crouzonodermoskeletal syndrome), and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans). | ||
28181399 |
MALE | Child |
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. | ||
Couser NL, Pande CK, Turcott CM, Spector EB, Aylsworth AS, Powell CM. Am J Med Genet A. 2017;173(4):1097-1101. |
||
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. | ||
28181399 |
MALE | Child |
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. | ||
Couser NL, Pande CK, Turcott CM, Spector EB, Aylsworth AS, Powell CM. Am J Med Genet A. 2017;173(4):1097-1101. |
||
We describe the clinical history of an 8-year-old child with a skeletal dysplasia in the achondroplasia-hypochondroplasia spectrum, acanthosis nigricans, typical development, and the recently described p.Ser348Cys FGFR3 mutation. | ||
25119967 |
FEMALE | Infant |
FGFR3-related condition: a skeletal dysplasia with similarities to thanatophoric dysplasia and SADDAN due to Lys650Met. | ||
Farmakis SG, Shinawi M, Miller-Thomas M, Radmanesh A, Herman TE. Skeletal Radiol. 2015;44(3):441-5. |
||
Mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for six related skeletal dysplasia conditions: achondroplasia, hypochondroplasia, thanatophoric dysplasia types 1 and 2, SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans), and platyspondylic lethal skeletal dysplasia, San Diego type. | ||
21510009 |
FEMALE | Child |
Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3. | ||
Berk DR, Boente Mdel C, Montanari D, Toloza MG, Primc NB, Prado MI, Bayliss SJ, Pique LM, Schrijver I. Pediatr Dermatol. 2010;27(6):664-6. |
||
Acanthosis nigricans has been described in several autosomal dominant skeletal dysplasia syndromes due to germline FGFR3 mutations, but rarely specifically in patients with hypochondroplasia. | ||
21510009 |
FEMALE | Child |
Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3. | ||
Berk DR, Boente Mdel C, Montanari D, Toloza MG, Primc NB, Prado MI, Bayliss SJ, Pique LM, Schrijver I. Pediatr Dermatol. 2010;27(6):664-6. |
||
We report a child who presented with extensive acanthosis nigricans, short stature, and radiographic evidence of hypochondroplasia. | ||
20453470 |
FEMALE | |
FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. | ||
Blomberg M, Jeppesen EM, Skovby F, Benfeldt E. Dermatology. 2010;220(4):297-305. |
||
We present a 14-year-old girl with mild hypochondroplasia who developed acanthosis nigricans. | ||
20453470 |
FEMALE | |
FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. | ||
Blomberg M, Jeppesen EM, Skovby F, Benfeldt E. Dermatology. 2010;220(4):297-305. |
||
FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. |